Not exact matches
Small molecules
binding to amyloid
fibrils.
In addition to uncovering compounds with therapeutic potential for Alzheimer's disease, this research presents a new approach for identifying proteins that
bind to amyloid
fibrils — an approach that could have broad applications for treating many diseases.
The final β - sheets
bind together and stack up to form the damaging
fibrils.
The amyloid - beta
bound itself to C. albicans and grew
fibrils that entombed the fungal invader — and as part of that process, created plaques of amyloid - beta.
Four of the mAbs, 2T5C9, 2G9C, T1F11, and TB2H7, demonstrated diagnostic potential in enzyme - linked immunosorbent assays (ELISA) by their low to sub-nanomolar cross-reactivity with recombinant wild - type (WT) and mutant TTR aggregates and lack of
binding to native TTR or amyloid
fibrils formed by other peptides or proteins.